Comparative study of the bacterial distribution and antimicrobial susceptibility of uropathogens in older and younger patients with urinary stones

Table 2 Comparison of top 15 most frequently detected uropathogens in urinary stone patients between older and younger

Older	N (%) N = 177	P	Younger	N (%) N = 365	P
Escherichia Coliⁿ	74 (41.8)	.699	Escherichia Coliⁿ	159 (43.6)	.699
E. coli ESBL (+)	45 (60.8)	.806	E. coli ESBL (+)	94(59.1)	.806
E. coli ESBL (−)	29 (39.2)		E. coli ESBL (−)	65(40.9)
Klebsiella pneumoniaeⁿ	17 (9.6)	.026*	Enterococcus faecalis^p	35 (9.6)	.186
K. pneumonia ESBL(+)	3 (17.6)	.244	Klebsiella pneumoniaeⁿ	17 (4.7)	.026*
K. pneumoniae ESBL(−)	14 (82.4)		K. pneumoniae ESBL(+)	6 (35.3)	.244
Enterococcus faecalis^p	11 (6.2)	.186	K. pneumoniae ESBL(−)	11 (64.7)
Enterococcus faecium^p	11 (6.2)	.049*	Candida glabrata^F	17 (4.7)	.036*
Pseudomonas aeruginosaⁿ	8 (4.5)	.278	Proteus mirabilisⁿ	13 (3.6)	.653
Candida albicans^F	5 (2.8)	.955	Candida albicans^F	10 (2.7)	.955
Proteus mirabilisⁿ	5 (2.8)	.653	Enterococcus faecium^p	10 (2.7)	.049*
Enterobacter cloacae^N	4 (2.3)	.741	Pseudomonas aeruginosaⁿ	10 (2.7)	.278
Candida glabrata^F	2 (1.1)	.036*	Enterobacter cloacae^N	10 (2.7)	.741
Staphylococcus aureus^p	2 (1.1)	.972	Candida tropicalis^F	8 (2.2)	.165
Candida parapsilosis^F	2 (1.1)	.642	Acinetobacter baumannii^N	6 (1.6)	0.047*
Acinetobacter lwoffii^N	2 (1.1)	.208	S. epidermidis^P	6 (1.6)	0.047*
Morgan Morganella^N	2 (1.1)	.458	Candida parapsilosis^F	6 (1.6)	.642
Aeromonas caviae^N	2 (1.1)	.208	Streptococcus agalactiae^P	5 (1.4)	.401
Burkholderia cepacia^N	2 (1.1)	.042	Staphylococcus aureus^p	4 (1.4)	.972

Chi-square test was performed to detect differences in specific uropathogens distribution. *P < 0.05 illustrates statistical significance. ^N Gram-negative, ^P Gram-positive, ^F Fungi

ISSN: 1471-2318